Revolab

Revolab offers remote blood testing and tracking through an at-home blood sample kit with AI-backed health insights.

Revolab is a HealthTech startup based in Vilnius that offers a remote blood testing and tracking platform powered by AI. By transforming lab-grade blood test data into health insights, it revolutionizes the way people monitor their medical care in Europe and beyond, all from the comfort of their own homes. Starting as a bold idea to simplify the blood testing process, they have grown their revenue to over 100,000 € and secured a seed funding of 300,000 € in May 2021.

Their at-home blood sample kit provides lab-grade results within 24 hours, reinforced with insights from general practitioners. With over 30 health test options, including Covid-19 testing, customers can track their results via their personal account. Revolab's CE-certified, FDA-approved in-vitro medical device is cleared for 27 EU markets and holds a medical license in Lithuania. Currently distributed via their website and app, Revolab is set to launch in neighboring countries by the end of 2021. They are also proud to be reimbursed by insurance partners Gjensidige and Compensa Group.